ATE391492T1 - Ophthalmische zusammensetzungen enthaltend galaktomannanpolymere und borat - Google Patents

Ophthalmische zusammensetzungen enthaltend galaktomannanpolymere und borat

Info

Publication number
ATE391492T1
ATE391492T1 AT03014536T AT03014536T ATE391492T1 AT E391492 T1 ATE391492 T1 AT E391492T1 AT 03014536 T AT03014536 T AT 03014536T AT 03014536 T AT03014536 T AT 03014536T AT E391492 T1 ATE391492 T1 AT E391492T1
Authority
AT
Austria
Prior art keywords
borate
compositions containing
ophthalmic compositions
galactomannan polymers
containing galactomannan
Prior art date
Application number
AT03014536T
Other languages
English (en)
Inventor
Bahram Asgharian
Original Assignee
Alcon Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21988983&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE391492(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alcon Lab Inc filed Critical Alcon Lab Inc
Application granted granted Critical
Publication of ATE391492T1 publication Critical patent/ATE391492T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/22—Boron compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/08—Mydriatics or cycloplegics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
AT03014536T 1997-07-29 1998-07-17 Ophthalmische zusammensetzungen enthaltend galaktomannanpolymere und borat ATE391492T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5413297P 1997-07-29 1997-07-29

Publications (1)

Publication Number Publication Date
ATE391492T1 true ATE391492T1 (de) 2008-04-15

Family

ID=21988983

Family Applications (2)

Application Number Title Priority Date Filing Date
AT98936847T ATE250923T1 (de) 1997-07-29 1998-07-17 Galaktomannanpolymere und borat enthaltende augenarzneimittel
AT03014536T ATE391492T1 (de) 1997-07-29 1998-07-17 Ophthalmische zusammensetzungen enthaltend galaktomannanpolymere und borat

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT98936847T ATE250923T1 (de) 1997-07-29 1998-07-17 Galaktomannanpolymere und borat enthaltende augenarzneimittel

Country Status (20)

Country Link
US (6) US6403609B1 (de)
EP (2) EP0999825B1 (de)
JP (2) JP3979783B2 (de)
KR (1) KR100507984B1 (de)
CN (3) CN1229110C (de)
AR (1) AR013272A1 (de)
AT (2) ATE250923T1 (de)
AU (1) AU737442B2 (de)
BR (1) BR9811574B1 (de)
CA (1) CA2296080C (de)
CY (2) CY1110365T1 (de)
DE (2) DE69839355T2 (de)
DK (2) DK0999825T3 (de)
ES (2) ES2302881T3 (de)
HK (2) HK1026618A1 (de)
LU (1) LU92301I2 (de)
PT (2) PT1348427E (de)
TW (2) TWI233801B (de)
WO (1) WO1999006023A1 (de)
ZA (1) ZA986533B (de)

Families Citing this family (147)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6872710B2 (en) * 1997-07-25 2005-03-29 Inspire Pharmaceuticals, Inc. Di(uridine 5′)-tetraphosphate and salts thereof
DK0970175T3 (da) 1997-07-29 2002-11-04 Alcon Lab Inc Konditioneringsopløsninger til pleje af hårde kontaktlinser
ATE250923T1 (de) 1997-07-29 2003-10-15 Alcon Lab Inc Galaktomannanpolymere und borat enthaltende augenarzneimittel
CA2431368C (en) * 2000-12-20 2006-08-08 Alcon, Inc. Intraocular irrigating solution having improved flow characteristics
AU2002230504A1 (en) 2000-12-20 2002-07-01 Alcon Universal Ltd. Ophthalmic irrigating solution adapted for use in lasik surgery
US7084130B2 (en) * 2001-12-11 2006-08-01 Alcon, Inc. Intraocular irrigating solution having improved flow characteristics
US20090258955A1 (en) * 2000-12-20 2009-10-15 Alcon, Inc. Intraocular irrigating solution having improved flow characteristics
AU2002232437A1 (en) 2000-12-20 2002-07-01 Alcon Universal Ltd. Ophthalmic lubricating solution adapted for use in lasik surgery
CA2431367C (en) * 2000-12-20 2010-02-09 Alcon, Inc. Solution for removing cataracts via liquefracture
GB2395507B (en) * 2001-06-22 2006-02-15 Bj Services Co Fracturing fluids and methods of making and using same
FR2832223B1 (fr) 2001-11-15 2005-01-14 Cit Alcatel Composant monolithique electro-optique multisections
MXPA04004915A (es) * 2001-12-21 2004-08-11 Alcon Inc Nanoparticulas inorganicas para modificar la viscosidad y las propiedades fisicas de composiciones oftalmicas y oticas.
JP4580649B2 (ja) * 2001-12-21 2010-11-17 アルコン、インコーポレイテッド ナノ粒子を殺生物剤の担体として眼科用組成物に使用する方法
SI1474109T1 (sl) 2001-12-21 2010-11-30 Alcon Inc Uporaba sintetičnih anorganskih nanodelcev kot nosilcev za oftalmična zdravila
CA2477044A1 (en) * 2002-02-22 2003-09-04 Pharmacia Corporation Ophthalmic formulation with gum system
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
ATE529447T1 (de) * 2002-06-25 2011-11-15 Rhodia Propfpolymerisation von guar durch elektronenstrahlen
BRPI0312077B1 (pt) 2002-06-25 2017-06-13 Rhodia, Inc. - Companhia Americana Method of depolymerization of polysaccharides
US8877168B1 (en) 2002-07-31 2014-11-04 Senju Pharmaceuticals Co., Ltd. Aqueous liquid preparations and light-stabilized aqueous liquid preparations
CN1293880C (zh) * 2002-07-31 2007-01-10 千寿制药株式会社 水性液体制剂和光稳定的水性液体制剂
DK1575569T3 (da) 2002-12-13 2011-01-10 Durect Corp Oralt indgivelsessystem omfattende flydende bærematerialer med høj viskositet
CA2839930C (en) * 2003-06-13 2016-07-05 Alcon, Inc. Ophthalmic compositions containing a synergistic combination of two polymers
AU2012205283B2 (en) * 2003-06-13 2014-08-07 Alcon, Inc. Ophthalmic compositions containing a synergistic combination of two polymers
US7947295B2 (en) 2003-06-13 2011-05-24 Alcon, Inc. Ophthalmic compositions containing a synergistic combination of two polymers
TWI336257B (en) * 2003-06-13 2011-01-21 Alcon Inc Ophthalmic compositions containing a synergistic combination of three polymers
US7914803B2 (en) 2003-06-13 2011-03-29 Alcon, Inc. Ophthalmic compositions containing a synergistic combination of three polymers
US20050129770A1 (en) * 2003-12-11 2005-06-16 Alcon, Inc. Ophthalmic compositions containing a PVA/borate gelling system
CA2545947A1 (en) * 2003-12-11 2005-07-07 Alcon, Inc. Ophthalmic compositions containing a polysaccharide/borate gelling system
US20050137166A1 (en) * 2003-12-19 2005-06-23 Alcon, Inc. Use of cooling agents to relieve mild ocular irritation and enhance comfort
EP1720579A1 (de) * 2004-02-17 2006-11-15 Wheli Inter AG Galaktomannane und/oder glucomannane zur erhöhung von wirkstoff-bioverfügbarkeit
TWI339659B (en) * 2004-03-18 2011-04-01 R Tech Ueno Ltd Aqueous composition comprising thiazole derivative
US7022740B2 (en) * 2004-04-29 2006-04-04 Leonard Mackles Lubricious ophthalmic solutions
KR100665299B1 (ko) * 2004-06-10 2007-01-04 서울반도체 주식회사 발광물질
ATE514412T1 (de) * 2004-08-03 2011-07-15 Rhodia Polysaccharid-pfropfcopolymere und ihre verwendung bei der haarpflege
JP4771044B2 (ja) * 2004-09-15 2011-09-14 大正製薬株式会社 粘膜適用液剤
EA014852B1 (ru) 2004-09-17 2011-02-28 Дьюрект Корпорейшн Система контролируемой доставки
US20070059274A1 (en) * 2004-12-01 2007-03-15 Bahram Asgharian Ophthalmic compositions containing a PVA/borate gelling system
US8318210B2 (en) 2005-02-28 2012-11-27 Neos Therapeutics, Lp Compositions and methods of making sustained release liquid formulations
US20070027105A1 (en) 2005-07-26 2007-02-01 Alza Corporation Peroxide removal from drug delivery vehicle
US20070048338A1 (en) * 2005-08-26 2007-03-01 Ladd Byron S Compositions and methods for surface treatment in medical and surgical procedures
US20100130580A1 (en) * 2006-01-25 2010-05-27 Aciex Therapeutics, Inc. Formulations and Methods for Treating Dry Eye
AU2007208054A1 (en) * 2006-01-25 2007-08-02 Aciex Therapeutics, Inc. Formulations and methods for treating dry eye
EP2035015A4 (de) * 2006-05-01 2009-11-11 Riolan Technologies Inc Zusammensetzungen, verfahren und kits zur behandlung des trockenen auges
WO2008036855A2 (en) * 2006-09-21 2008-03-27 Alcon Research, Ltd. Self-preserved aqueous pharmaceutical compositions
TWI394564B (zh) * 2006-09-21 2013-05-01 Alcon Res Ltd 自行保存型水性藥學組成物
US8388941B2 (en) * 2006-09-28 2013-03-05 Alcon Research, Ltd. Self preserved aqueous pharmaceutical compositions
PT2117521E (pt) 2006-11-03 2012-09-10 Durect Corp Sistemas de administração transdérmica que compreendem bupivacaína
WO2008088601A2 (en) * 2007-01-16 2008-07-24 Texas Tech University System Method and apparatus for gender selection based on ph
ZA200904917B (en) * 2007-02-09 2010-09-29 Alcon Inc Ophthalmic compositions containing a synergistic combination of three polymers
JP2010520766A (ja) * 2007-03-09 2010-06-17 コーニング インコーポレイテッド 細胞培養用三次元ガムマトリックス、製造方法および使用方法
US20080220526A1 (en) * 2007-03-09 2008-09-11 Ellison Adam J Gum coatings for cell culture, methods of manufacture and methods of use
CA2687717A1 (en) * 2007-05-24 2008-12-18 Aciex Therapeutics, Inc. Formulations and methods for treating dry eye
US20090131303A1 (en) * 2007-11-16 2009-05-21 Bor-Shyue Hong Methods and compositions for treating dry eye
AU2008347158B8 (en) 2007-12-06 2013-08-22 Durect Corporation Oral pharmaceutical dosage forms
US7795316B1 (en) 2007-12-19 2010-09-14 Alcon Research, Ltd. Topical ophthalmic compositions containing tobramycin and dexamethasone
PT2254549E (pt) * 2008-03-17 2014-01-30 Alcon Res Ltd Composições farmacêuticas aquosas que contêm complexos de borato-poliol
JP5659149B2 (ja) * 2008-04-26 2015-01-28 アルコン リサーチ， リミテッド ポリマー性人工涙液系
US20100260844A1 (en) 2008-11-03 2010-10-14 Scicinski Jan J Oral pharmaceutical dosage forms
US20100196415A1 (en) * 2009-02-05 2010-08-05 Alcon Research, Ltd. Process for purifying guar
TW201039815A (en) 2009-04-13 2010-11-16 Resolvyx Pharmaceuticals Inc Compositions and methods for the treatment of inflammation
TWI489997B (zh) 2009-06-19 2015-07-01 Alcon Res Ltd 含有硼酸－多元醇錯合物之水性藥學組成物
TWI547522B (zh) 2009-07-07 2016-09-01 愛爾康研究有限公司 環氧乙烷環氧丁烷嵌段共聚物組成物
US8921337B2 (en) * 2009-12-03 2014-12-30 Alcon Research, Ltd. Carboxyvinyl polymer-containing nanoparticle suspensions
TWI478730B (zh) * 2009-12-03 2015-04-01 Alcon Res Ltd 眼科乳劑
CN102939074A (zh) * 2010-05-05 2013-02-20 爱尔康研究有限公司 稳定的眼科半乳甘露聚糖制剂
MX2012015051A (es) * 2010-06-23 2013-02-15 Alcon Res Ltd Suspenciones oftalmicas topicas que contienen tobramicina y dexametasona.
RS54750B1 (sr) 2010-10-26 2016-10-31 Mars Inc Borati kao inhibitori arginaze
CN104039307A (zh) 2011-04-22 2014-09-10 爱尔康研究有限公司 具有包含两种不同粘度增强剂的粘度增强体系的眼用组合物
EP3045163A1 (de) 2011-04-22 2016-07-20 Alcon Research, Ltd. Ophthalmische zusammensetzung mit einem viskositätsverstärkungssystem mit zwei unterschiedlichen viskositätsverstärkern
SG11201402305WA (en) 2011-11-21 2014-06-27 Calithera Biosciences Inc Heterocyclic inhibitors of glutaminase
TW201336527A (zh) * 2012-02-10 2013-09-16 Alcon Res Ltd 具增強的穩定性之水性藥學組成物
UA113434C2 (uk) 2012-05-04 2017-01-25 Алкон Рісерч, Лтд. Офтальмологічна композиція з поліпшеним захистом від зневоднювання й утриманням
CN102860949B (zh) * 2012-08-31 2014-07-02 马应龙药业集团股份有限公司 眼部抗皱护肤品及其制备方法
MX2015005963A (es) 2012-11-16 2015-09-16 Calithera Biosciences Inc Inhibidores heterociclicos de glutaminasa.
CN105120659A (zh) 2013-03-15 2015-12-02 度瑞公司 用于降低溶解可变性的具有流变改性剂的组合物
EP3013790A1 (de) 2013-06-27 2016-05-04 Mylan Laboratories Ltd. Verfahren zur herstellung von nepafenac
WO2015055301A1 (en) 2013-10-15 2015-04-23 Pharmathen S.A. Preservative free pharmaceutical compositions for ophthalmic administration
FR3000391B3 (fr) 2013-11-12 2015-02-20 Pharmathen Sa Compositions pharmaceutiques sans conservateur pour administration ophtalmique
CN103572651B (zh) * 2013-11-25 2016-05-04 齐鲁工业大学 一种改性塔拉胶及其制备方法与应用
EP3119392A4 (de) * 2014-03-17 2017-10-11 Encompass Development Inc. Augenformulierungen
JP6798890B2 (ja) 2014-06-13 2020-12-09 キャリセラ バイオサイエンシーズ， インコーポレイテッド グルタミナーゼ阻害剤との併用療法
BR112017002403A2 (pt) 2014-08-07 2017-12-05 Calithera Biosciences Inc formas de cristais de inibidores de glutaminase
UY36272A (es) 2014-08-13 2016-02-29 Eolas Therapeutics Inc Difluoropirrolidinas como moduladores de los receptores de orexinas
WO2016061147A1 (en) 2014-10-13 2016-04-21 John Eric Paderi Luminal vessel coating for arteriovenous fistula
WO2016061145A1 (en) 2014-10-13 2016-04-21 Symic Biomedical, Inc. Synthetic proteoglycans for preventing tissue adhesion
WO2016065083A1 (en) 2014-10-21 2016-04-28 Symic Biomedical, Inc. Peptidoglycans comprising collagen-binding peptides for treating gastroesophageal injury
AU2016230793B2 (en) 2015-03-10 2021-03-25 Aurigene Discovery Technologies Limited 1,2,4-oxadiazole and thiadiazole compounds as immunomodulators
CA2990192A1 (en) 2015-06-23 2016-12-29 Calithera Biosciences, Inc. Compositions and methods for inhibiting arginase activity
CA2994540A1 (en) 2015-08-03 2017-02-09 Ecolab Usa Inc. Compositions and methods for delayed crosslinking in hydraulic fracturing fluids
GB2542881B (en) 2015-10-02 2020-01-01 Carr Andrew Crystal forms of ß-nicotinamide mononucleotide
JP6971239B2 (ja) 2015-10-05 2021-11-24 キャリセラ バイオサイエンシーズ， インコーポレイテッド グルタミナーゼ阻害剤とイムノオンコロジー薬剤との併用療法
WO2017066349A1 (en) 2015-10-13 2017-04-20 Symic Ip, Llc Ve-cadherin binding bioconjugate
CN107847604B (zh) 2015-10-25 2020-11-10 艾威药业(珠海)有限公司 眼用原位凝胶处方
EP4011887A1 (de) 2015-10-30 2022-06-15 Calithera Biosciences, Inc. Zusammensetzungen und verfahren zur hemmung der arginaseaktivität
BR112018009946A8 (pt) 2015-11-16 2019-02-26 Ichorion Therapeutics Inc pró-fármacos de ácido nucleico
JP6703408B2 (ja) * 2016-01-30 2020-06-03 国立大学法人 筑波大学 ポリイオンコンプレックスを有効成分とするドライアイ処置用組成物
EP3414241B1 (de) 2016-02-12 2022-05-04 Astrazeneca AB Halo-substituierte piperidine als orexinrezeptormodulatoren
US10087363B2 (en) * 2016-03-15 2018-10-02 Baker Hughes, A Ge Company, Llc Using borated galactomannan to enhance swelling of superabsorbents for fracturing applications
US10793590B2 (en) 2016-06-03 2020-10-06 President And Fellows Of Harvard College Antifungal compounds
CA3030763A1 (en) 2016-07-15 2018-01-18 Ecolab Usa Inc. Compositions and methods for delayed crosslinking in hydraulic fracturing fluids
EP3509583B1 (de) 2016-09-09 2021-06-30 The Regents of the University of California Östrogenrezeptorliganden, zusammensetzungen und zugehörige verfahren
CN110234656B (zh) 2016-09-09 2023-02-28 卡利泰拉生物科技公司 外核苷酸酶抑制剂及其使用方法
EP3512834A4 (de) 2016-09-14 2020-05-06 Vanderbilt University Hemmung von bmp-signalisierung, verbindungen, zusammensetzungen und verwendungen davon
JP7203018B2 (ja) 2016-09-26 2023-01-12 デイナ ファーバー キャンサー インスティチュート，インコーポレイテッド クロモボックスタンパク質阻害剤およびその使用
KR20190104521A (ko) 2016-11-08 2019-09-10 칼리테라 바이오사이언시즈, 인코포레이티드 아르기나제 억제제 병용 요법들
AU2017382405B2 (en) 2016-12-22 2021-12-16 Calithera Biosciences, Inc. Compositions and methods for inhibiting arginase activity
JP2020511424A (ja) 2017-01-18 2020-04-16 ヴァンダービルト ユニバーシティーＶａｎｄｅｒｂｉｌｔ Ｕｎｉｖｅｒｓｉｔｙ 選択的ｂｍｐ阻害としての縮合複素環式化合物
EP3585772B1 (de) 2017-02-24 2023-10-11 Merck Patent GmbH 1,4,6-trisubstituierte-2-alkyl-1h-benzo[d]imidazolderivate als hemmer der dihydroorotat-oxygenase
SI3600270T1 (sl) 2017-03-31 2023-10-30 Aurigene Oncology Limited Spojine in sestavki za zdravljenje hematoloških motenj
US10994025B2 (en) 2017-05-12 2021-05-04 Massachusetts Institute Of Technology Argonaute protein-double stranded RNA complexes and uses related thereto
US11325943B2 (en) 2017-06-02 2022-05-10 Stealth Biotherapeutics Inc. Crystalline salt forms of SBT-20
EP3655379B1 (de) 2017-07-19 2023-04-05 California Institute of Technology Verfahren zur herstellung von verbindungen mit bis-tetrahydroisochinolin
SG11202003081WA (en) 2017-10-11 2020-05-28 Aurigene Discovery Tech Ltd Crystalline forms of 3-substituted 1,2,4-oxadiazole
EP4234037A3 (de) 2017-10-19 2023-09-06 Signpath Pharma, Inc. Flüssige zusammensetzungen zur peroralen verwendung umfassend phosphatidylglycerol derivate und thixotropische hilfsstoffe zur behandlung von herzkanalopathien verursacht durch pharmakologische wirkstoffe
EP3704108B1 (de) 2017-10-31 2024-04-24 Curis, Inc. Irak4-inhibitor in kombination mit einem bcl-2-inhibitor zur verwendung bei der behandlung von krebs
WO2019087087A1 (en) 2017-11-03 2019-05-09 Aurigene Discovery Technologies Limited Dual inhibitors of tim-3 and pd-1 pathways
CN111386128A (zh) 2017-11-06 2020-07-07 奥瑞基尼探索技术有限公司 用于免疫调节的联合疗法
UY38027A (es) 2017-12-22 2019-07-31 Medimmune Ltd Moduladores de molécula pequeña del dominio btb de keap1
TW201938141A (zh) 2018-02-21 2019-10-01 瑞士商諾華公司 基於脂質的眼用乳劑
WO2019178383A1 (en) 2018-03-14 2019-09-19 Vanderbilt University Inhibition of bmp signaling, compounds, compositions and uses thereof
SG11202100429TA (en) 2018-07-27 2021-02-25 California Inst Of Techn Cdk inhibitors and uses thereof
CN110787126A (zh) * 2018-08-03 2020-02-14 武汉武药科技有限公司 一种盐酸莫西沙星眼用凝胶及其制备方法
CA3111217A1 (en) 2018-09-05 2020-03-12 The General Hospital Corporation Methods of treating cytokine release syndrome
CA3117695A1 (en) 2018-10-26 2020-04-30 Keros Therapeutics, Inc. Crystal forms of an alk2 inhibitor
CN113727736A (zh) 2018-12-10 2021-11-30 通用医疗公司 色甘酸酯及其用途
US11248001B2 (en) 2019-01-18 2022-02-15 Astrazeneca Ab PCSK9 inhibitors and methods of use thereof
JP2022525157A (ja) 2019-03-14 2022-05-11 アストラゼネカ・アクチエボラーグ 体重減少のためのラナベセスタット
JP6890865B1 (ja) 2019-06-03 2021-06-18 株式会社大分大学先端医学研究所 狂犬病治療のための環状アミド化合物およびその方法
TWI757773B (zh) * 2019-06-28 2022-03-11 瑞士商愛爾康公司 眼用組成物
US11931454B2 (en) 2019-09-18 2024-03-19 Alcon Inc. Wet-packed soft hydrogel ocular inserts
CA3157798A1 (en) 2019-11-12 2021-05-20 Zhongli Gao 6-membered heteroarylaminosulfonamides for treating diseases and conditions mediated by deficient cftr activity
WO2021113809A1 (en) 2019-12-05 2021-06-10 Genzyme Corporation Arylamides and methods of use thereof
WO2021113806A1 (en) 2019-12-05 2021-06-10 Genzyme Corporation Arylamides and methods of use thereof
US20230088747A1 (en) 2019-12-16 2023-03-23 Unist (Ulsan National Institute Of Science And Technology) Compounds for inhibiting neovascularization factors and use thereof
CN115666621A (zh) 2020-01-13 2023-01-31 度勒科特公司 具有减少的杂质的持续释放药物递送系统及相关方法
TW202309022A (zh) 2021-04-13 2023-03-01 美商努法倫特公司 用於治療具egfr突變之癌症之胺基取代雜環
WO2023034992A1 (en) 2021-09-03 2023-03-09 Genzyme Corporation Indole compounds and methods of use
WO2023034946A1 (en) 2021-09-03 2023-03-09 Genzyme Corporation Indole compounds and uses thereof in the treatement of cystic fibrosis
TW202320768A (zh) 2021-10-01 2023-06-01 美商努法倫特公司 雜芳族大環醚化合物之固體形式、醫藥組成物及製備
WO2023056431A1 (en) 2021-10-01 2023-04-06 Nuvalent, Inc. Methods of treating solid tumor using heteroaromatic macrocyclic ether compounds
CN114191378A (zh) * 2021-11-23 2022-03-18 温州医科大学附属眼视光医院 一种地夸磷索缓释凝胶及其制备方法与应用
WO2023187672A1 (en) 2022-03-31 2023-10-05 Alcon Inc. Ophthalmic compositions
TW202400608A (zh) 2022-04-07 2024-01-01 美商努法倫特公司 雜芳族巨環醚化合物之固體形式、醫藥組合物及製備
WO2023196910A1 (en) 2022-04-07 2023-10-12 Nuvalent, Inc Methods of treating solid tumor using (19r)-5-chloro-3-ethyl-16-fluoro-10,19-dimethyl-20-oxa-3,4,10,11,23-pentaazapentacyclo[19.3.1.02,6.08,12.013,18]pentacosa-1(24),2(6),4,8,11,13,15,17,21(25),22-decaen-22-amine
WO2023224961A1 (en) 2022-05-16 2023-11-23 Exelixis, Inc. Cancer therapy using a combination of a cdk7 inhibitor with an oral serd
WO2024036097A1 (en) 2022-08-12 2024-02-15 Nuvalent, Inc. Heteroaromatic macrocyclic ether compounds and isotopologues thereof
WO2024036098A1 (en) 2022-08-12 2024-02-15 Nuvalent, Inc. Heteroaromatic macrocyclic ether compounds

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3944427A (en) * 1970-04-06 1976-03-16 Itek Corporation Gelable and gelled compositions
US3843782A (en) 1971-07-26 1974-10-22 Flow Pharma Inc Eye solution and method of using same
US4136173A (en) 1977-01-31 1979-01-23 American Home Products Corp. Mixed xanthan gum and locust beam gum therapeutic compositions
US4136178A (en) * 1977-01-31 1979-01-23 American Home Products Corp. Locust bean gum therapeutic compositions
US4136177A (en) * 1977-01-31 1979-01-23 American Home Products Corp. Xanthan gum therapeutic compositions
US4255415A (en) 1978-11-22 1981-03-10 Schering Corporation Polyvinyl alcohol ophthalmic gel
US4370325A (en) 1979-03-30 1983-01-25 Dermik Laboratories Pharmaceutical compositions and method of treatment
US4436730A (en) 1979-06-25 1984-03-13 Polymer Technology Corporation Ionic opthalmic cellulose polymer solutions
US4624868A (en) * 1979-12-17 1986-11-25 Colgate-Palmolive Company Borated polysaccharide absorbents and absorbent products
US4323467A (en) 1980-11-24 1982-04-06 Syntex (U.S.A.) Inc. Contact lens cleaning, storing and wetting solutions
JPS57186733A (en) 1981-05-13 1982-11-17 Toyo Contact Lens Co Ltd Agent for use in contact lenses
US4362781A (en) * 1981-09-21 1982-12-07 Scott Paper Company Flushable premoistened wiper
US4474751A (en) 1983-05-16 1984-10-02 Merck & Co., Inc. Ophthalmic drug delivery system utilizing thermosetting gels
FR2588189B1 (fr) 1985-10-03 1988-12-02 Merck Sharp & Dohme Composition pharmaceutique de type a transition de phase liquide-gel
US5457093A (en) 1987-09-18 1995-10-10 Ethicon, Inc. Gel formulations containing growth factors
US5188826A (en) 1988-02-08 1993-02-23 Insite Vision Incorporated Topical ophthalmic suspensions
US5192535A (en) 1988-02-08 1993-03-09 Insite Vision Incorporated Ophthalmic suspensions
US5607698A (en) 1988-08-04 1997-03-04 Ciba-Geigy Corporation Method of preserving ophthalmic solution and compositions therefor
US5126141A (en) 1988-11-16 1992-06-30 Mediventures Incorporated Composition and method for post-surgical adhesion reduction with thermo-irreversible gels of polyoxyalkylene polymers and ionic polysaccharides
CA2011423A1 (en) 1989-03-07 1990-09-07 Peter M. Taylor Pharmaceutical compositions useful as drug delivery vehicles and/or as wound dressings
US5160643A (en) 1990-01-16 1992-11-03 Bj Services Company Method for delaying the gellation of borated galactomannans with a delay additive such as glyoxal
US5145590A (en) 1990-01-16 1992-09-08 Bj Services Company Method for improving the high temperature gel stability of borated galactomannans
US5082579A (en) * 1990-01-16 1992-01-21 Bj Services Company Method and composition for delaying the gellation of borated galactomannans
US5346703A (en) 1990-08-07 1994-09-13 Mediventures, Inc. Body cavity drug delivery with thermo-irreversible polyoxyalkylene and ionic polysaccharide gels
US5376693A (en) 1990-08-07 1994-12-27 Mediventures Inc. Thermo-irreversible gel corneal contact lens formed in situ
US5077033A (en) 1990-08-07 1991-12-31 Mediventures Inc. Ophthalmic drug delivery with thermo-irreversible gels of polxoxyalkylene polymer and ionic polysaccharide
US5318780A (en) 1991-10-30 1994-06-07 Mediventures Inc. Medical uses of in situ formed gels
US5922340A (en) 1992-09-10 1999-07-13 Children's Medical Center Corporation High load formulations and methods for providing prolonged local anesthesia
US5372732A (en) 1992-10-21 1994-12-13 Halliburton Company Delayed release borate crosslinking agent
WO1994010976A1 (en) 1992-11-16 1994-05-26 Ciba Vision Ag, Hettlingen Polyvinyl alcohol/borate ophthalmic drug delivery system
JPH06345653A (ja) 1993-06-08 1994-12-20 Asahi Chem Ind Co Ltd 点眼液
US5773025A (en) 1993-09-09 1998-06-30 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems--amorphous drugs
US5603929A (en) 1994-11-16 1997-02-18 Alcon Laboratories, Inc. Preserved ophthalmic drug compositions containing polymeric quaternary ammonium compounds
US5972326A (en) 1995-04-18 1999-10-26 Galin; Miles A. Controlled release of pharmaceuticals in the anterior chamber of the eye
IT1283911B1 (it) 1996-02-05 1998-05-07 Farmigea Spa Soluzioni oftalmiche viscosizzate con polisaccaridi della gomma di tamarindo
GB9603146D0 (en) 1996-02-15 1996-04-17 Innovative Tech Ltd Hydrogels
JP3989054B2 (ja) 1996-07-29 2007-10-10 株式会社メニコン コンタクトレンズ用洗浄材
JPH10221654A (ja) 1997-02-07 1998-08-21 Seiko Epson Corp コンタクトレンズ用溶液
EP0999854B1 (de) * 1997-07-29 2003-10-01 Alcon Manufacturing Ltd. Galaktomannanpolymere und borat enthaltende viskoelastische systeme mit regelbarer viskosität
ATE250923T1 (de) * 1997-07-29 2003-10-15 Alcon Lab Inc Galaktomannanpolymere und borat enthaltende augenarzneimittel
DK0970175T3 (da) * 1997-07-29 2002-11-04 Alcon Lab Inc Konditioneringsopløsninger til pleje af hårde kontaktlinser
CA2545947A1 (en) * 2003-12-11 2005-07-07 Alcon, Inc. Ophthalmic compositions containing a polysaccharide/borate gelling system

Also Published As

Publication number Publication date
BR9811574B1 (pt) 2010-11-30
PT999825E (pt) 2004-02-27
CN1544092A (zh) 2004-11-10
ZA986533B (en) 1999-02-05
CN1762381A (zh) 2006-04-26
US20070098677A1 (en) 2007-05-03
EP1348427B1 (de) 2008-04-09
CY2013040I2 (el) 2015-11-04
AR013272A1 (es) 2000-12-13
JP4673339B2 (ja) 2011-04-20
PT1348427E (pt) 2008-05-26
AU8570598A (en) 1999-02-22
CN1762381B (zh) 2012-07-11
US20030206970A1 (en) 2003-11-06
TWI233801B (en) 2005-06-11
JP3979783B2 (ja) 2007-09-19
US20020183280A1 (en) 2002-12-05
CN100408100C (zh) 2008-08-06
US6838449B2 (en) 2005-01-04
CN1302201A (zh) 2001-07-04
CN1229110C (zh) 2005-11-30
DE69839355T2 (de) 2009-06-04
CA2296080A1 (en) 1999-02-11
DE69818675T2 (de) 2004-07-29
KR100507984B1 (ko) 2005-08-17
US20050075313A1 (en) 2005-04-07
JP2007197461A (ja) 2007-08-09
US6486138B1 (en) 2002-11-26
CA2296080C (en) 2005-02-01
ES2302881T3 (es) 2008-08-01
DE69839355D1 (de) 2008-05-21
EP0999825B1 (de) 2003-10-01
JP2003528797A (ja) 2003-09-30
DK0999825T3 (da) 2004-02-09
WO1999006023A1 (en) 1999-02-11
ES2206965T3 (es) 2004-05-16
CY1110365T1 (el) 2015-04-29
DK1348427T3 (da) 2008-06-30
BR9811574A (pt) 2000-08-29
HK1055392A1 (en) 2004-01-09
AU737442B2 (en) 2001-08-16
US6403609B1 (en) 2002-06-11
HK1026618A1 (en) 2000-12-22
EP1348427A1 (de) 2003-10-01
KR20010022286A (ko) 2001-03-15
US6583124B2 (en) 2003-06-24
TW577751B (en) 2004-03-01
DE69818675D1 (de) 2003-11-06
ATE250923T1 (de) 2003-10-15
EP0999825A1 (de) 2000-05-17
US7169767B2 (en) 2007-01-30
LU92301I2 (fr) 2013-12-31
CY2013040I1 (el) 2015-11-04

Similar Documents

Publication Publication Date Title
ATE391492T1 (de) Ophthalmische zusammensetzungen enthaltend galaktomannanpolymere und borat
DE69812946T2 (de) Ethylenpolymerzusammensetzungen und daraus hergestellte gegenstände
ID24592A (id) Metoda dan komposisi-komposisi untuk pemutihan gigi
DE69811293D1 (de) Polymerzusammensetzungen
BR9800344A (pt) Composição de vidro e utilização das composições de vidro
ATE193712T1 (de) Vinylaromat-blockcopolymere und dieselben enthaltende zusammensetzungen
NO985123D0 (no) FremgangsmÕter og sammensetninger for brytning av viskoseregulerte fluider
DE69818053D1 (de) Gefüllte polymerzusammensetzungen
BR9710462A (pt) Naftopirans composicoes e artigos contendo as mesmas
DE69706500D1 (de) Hitzebeständige Polyamid-Zusammensetzung und sie enthaltende Fasern
ID24196A (id) Komposisi dan penggunaan
ATE265497T1 (de) Hydrierte blockcopolymerzusammensetzungen und verwendungen davon
DE60020710D1 (de) Hydrierte blockcopolymerzusammensetzungen und verwendungen davon
DE69918842D1 (de) Desinfektionszusammensetzungen und verfahren
ATE250939T1 (de) Galaktomannanpolymere und borat enthaltende viskoelastische systeme mit regelbarer viskosität
DE60039001D1 (de) Wasserabsorbierendes optisches Gel und ophthalmische Zusammensetzung
ID21391A (id) Komposisi pelindung cahaya
HUP9903241A3 (en) Light protective cosmetical compositions and their use
DE69813488D1 (de) Härtbare Zusammensetzungen und gehärtete Gel-Gegenstände daraus
DE975695T1 (de) Zusammensetzungen, enthaltend gleit- und antiblockmittel
DE69820919D1 (de) Mit Wasser quellbare Zusammensetzungen und Dichtungsmassen
DE69807706D1 (de) Glaszusammensetzung und optische vorrichtung daraus hergestellt
BR9504266A (pt) Formulação de dispersão viscoelástica
DE69736512D1 (de) Polymer-PCT-Zusammensetzung und damit hergestellte Schaltungsschutzeinrichtung
FR2749842B1 (fr) Compositions de verres opalins

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1348427

Country of ref document: EP